0001938281-24-000001.txt : 20240129 0001938281-24-000001.hdr.sgml : 20240129 20240129100532 ACCESSION NUMBER: 0001938281-24-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240129 DATE AS OF CHANGE: 20240129 EFFECTIVENESS DATE: 20240129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CorriXR Therapeutics, Inc. CENTRAL INDEX KEY: 0001938281 ORGANIZATION NAME: IRS NUMBER: 881652983 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-452572 FILM NUMBER: 24570966 BUSINESS ADDRESS: STREET 1: 501 WEST 14TH STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302-623-5305 MAIL ADDRESS: STREET 1: 501 WEST 14TH STREET CITY: WILMINGTON STATE: DE ZIP: 19801 D/A 1 primary_doc.xml X0708 D/A LIVE 0001938281 CorriXR Therapeutics, Inc. 550 S. College Avenue, Suite 107 Newark DE DELAWARE 19713 302-623-5305 DELAWARE None None Corporation true 2022 Eric Kmiec 550 S. College Avenue, Suite 107 Newark DE DELAWARE 19713 Executive Officer Director Jeffrey Carper 550 S. College Avenue, Suite 107 Newark DE DELAWARE 19713 Director Janice Nevin 550 S. College Avenue, Suite 107 Newark DE DELAWARE 19713 Director Deborah Moorad 550 S. College Avenue, Suite 107 Newark DE DELAWARE 19713 Executive Officer Director Stella Vnook 550 S. College Avenue, Suite 107 Newark DE DELAWARE 19713 Director Jon Brilliant 550 S. College Avenue, Suite 107 Newark DE DELAWARE 19713 Executive Officer Biotechnology Decline to Disclose 06b true 0001878646-22-000032 2022-06-30 true true false 0 8028610 6525179 1503431 false 4 0 0 0 false CorriXR Therapeutics, Inc. /s/ Deborah Moorad Deborah Moorad Chief Executive Officer 2024-01-29